Heart and Blood Pressure


The heart is one of our most vital organs. For decades, science has tried to investigate and understand heart disease to the best of its ability. According to the World Health Organization (WHO), the leading cause of death remains cardiovascular disease (1-3). Despite all research and immense drug development to prevent cardiovascular disease, the incidence and prevalence of people with too high blood pressure keep rising (4). Over time, this might cause severe heart disease, heart failure and even damage to other organs, such as the kidneys (5). 

Cardiovascular risk factors not only increase in the elderly population, but also in the younger, and even (young) athletic population (6). 

Risk factors of cardiovascular disease: absent to miniml physical activity, obesity, unhealthy nutrition, smoking, diabetes, chronic stress or anxiety (7). The underlying cause of all these risk factors seems to be due to inflammation in the vessel walls and the simultaneous fat accumulation in the blood vessels. This fat accumulation in vessel walls is called atherosclerosis. 

Seeing lifestyle and diet play an important role in reversing or even preventing cardiovascular disease, natural nutrients have become more and more popular.


Marine Phytoplankton contains a combination of antioxidants, omega-3 fatty acids, unique natural pigments, essential amino acids, peptides, vitamins, minerals, and other substances that support the heart (8-9).  

The body cannot synthesize these substances themselves, so you want to get them through your daily nutrition. Moreover, studies show that with our diet alone, we are not able to obtain sufficient amounts of these substances through our usual diets (10). Especially omega-3 fatty acids have shown to have positive effects on the cardiovascular system: Did you know that Marine Phytoplankton is a primary producer of omega-3 fatty acids? No need to consume fish-oil when Marine Phytoplankton offers you the source of these essential fatty acids. 

What does science say about marine phytoplankton?

Numerous studies suggest that various types of nutrition in Marine Phytoplankton can have a positive influence on the heart and blood vessels. Marine Phytoplankton is a primary producer of omega 3 fatty acids (O3FAs), unique pigments, peptides, and many vitamins and minerals (11-14). These components have separately shown antihypertensive properties, capable of lowering blood pressure. The substances in Marine Phytoplankton are able to exert various effects, such as:

- Directly lowering blood pressure by inhibiting ACE-enzyme (15). This is the same principe as in ACE-inhibiting medication (16)

- Directly lowering blood pressure by causing vasodilation - widening of vessels (17-20).

- Neutralizing inflammation to prevent excessive collateral damage to the heart and vessels (21-28). 

- Preventing formation of harmful blood clots (29-31). 

- Inhibiting the deposition of plaques in the artery wall (32-34). 

- Reducing cholesterol and triglycerides, preventing their accumulation in the vessel wall (35-37). 

- Improving blood vessel functioning and improving its elasticity (38). 

- Stabilizing heart rate and heart rhythm (39). 



Omega-3 fatty acids might prevent or slow down the development of heart disease or heart failure by inhibiting inflammation. Interestingly, higher levels of omega-3 fatty acids seem to be associated with a significant lower blood pressure in young and otherwise healthy people (40). Did you know that algae, and not fish - are the source of these fatty acids? (41)

Marine phytoplankton contains unique pigments: carotenoids

Carotenoids are a class of natural fat-soluble pigments founds principally in plants, and in uniquely high concentrations in algae (42). We humans are not capable of synthesizing them, which makes it necessary to incorporate them in our nutrition. One of the most important carotenoids in Marine phytoplankton is beta-carotene (43-44), astaxanthin (45-46), fucoxanthin (47-51), lycopene (52-56), and many others (57-58). These carotenoids each have unique anti-hypertensive and anti-oxidative properties. 

What makes the carotenoids even beneficial for our health and heart is their additional antioxidative (detox) effect (59).

read more about detox

Don’ forget, nutrition is just one piece of the puzzle, don’t forget to:

1. Move and exercise more (60)

2. Lower your sodium intake (61)

3. Don't smoke or stop smoking (62)

4. Try to prevent anxiety and deal with stress (63)

5. Take a conscious look at your nutrition and supplements. Bad nutrition is associated with a higher risk of cardiovascular disease (64). As mentioned before, our typical diet is lacking substances that could support our cardiovascular system. 


we need to minimize risk factors as much as possible by implementing a healthy and conscious lifestyle and diet. However, seeing out typical daily diet is lacking substances that support our heart, consider adding Marine Phytoplankton to your daily diet. The nutrients in Marine Phytoplankton offer numerous potential effects that prevent or counteract cardiovascular disease .

Lastly, this is not a replacement of antihypertensive medicine. Always consult your medical doctor before replacing Marine Phytoplankton as a natural antihypertensive medicine.


Discover marine phytoplankton

Marine Phytoplankton, an "all-in-one" superfood full of natural nutrients. 

Besides being the source of Omega-3 fatty acids, Marine Phytoplankton is rich in vitamins minerals and strong antioxidants. 

The perfect supplementation to your daily nutritional needs. Discover it now:



Please click below to see which scientific articles were used to gather information concerning the subject.

Click here

(1). Kung HC, Xu JQ. Hypertension-related mortality in theUnited States, 2000–2013. NCHS data brief, no 193.Hyattsville, MD: NationalCenter for Health Statistics; 2015.


(2). Lloyd-Jones et al. “Executive summary: heart disease and strokestatistics--2010 update: a report from the American Heart Association”Circulation 2010 Feb 23;121(7):948-54.


(3). Kearney et al. “Global burden of hypertension: analysis of worldwide data” Lancet. 2005 Jan 15-21;365(9455):217-23.


(4). Pleis et al. “Summary health statistics for U.S. adults: NationalInterview Survey, 2008” Vital Health Stat 10. 2009Dec;(242):1-157.


(5). Romagnani et al. “Chronic kidney disease” Nat Rev Dis Primers. 2017 Nov 23;3:17088.


(6).Venecia et al. “Hypertension in young adults” Postgrad Med. 2016;128(2):201-7.


(7). Murray et al. “Overweight across the life course and adipokines, inflammatory and endothelial markers at age 60-64 years: evidence from the 1946birth cohort” International Journey of Obesity. 2015 Jun;39(6):1010-8.

(8). Norris, FitzGerald “AntihypertensivePeptides from food proteins. Bioactive Food Peptides in Health and Disease”InTech. 2013.

(9). Girgih et al. “Preventive and treatment effects of a hemp seed(Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats”. European Journal of Nutrition. 2014 Aug;53(5):1237-46.


(10). Liu JC et al. “Long-chain omega-3 fatty acids and blood pressure” Am J Hypertens 2011; 24:1121–1126.


(11). Jónasdóttir S. “Fatty Acid Profiles and Production in Marine Phytoplankton”Marine Drugs. 2019 Mar 4;17(3):151.


(12). Harwood J. “Algae: Critical Sources of Very Long-ChainPolyunsaturated Fatty Acids” Biomolecules. 2019Nov 6;9(11):708.


(13). Levasseur et al. “A review of high value-added molecules production by microalgae in light of the classification” Bio technology advances Jul-Aug 2020;41:107545.


(14). Ju Z.Y., Deng D.-F., Dominy W. A defatted microalgae(Haematococcus pluvialis) meal as a protein ingredient to partially replace fish meal in diets of Pacific white shrimp (Litopenaeus vannamei, Boone, 1931)Aquaculture. 2012;354:50–55. doi:10.1016/j.aquaculture.2012.04.028


(15). Yang et al. “Lowering Effects of n-3 Fatty Acid Supplements on Blood Pressure by Reducing Plasma Angiotensin IIin Inner Mongolia Hypertensive Patients: A Double-Blind Randomized ControlledTrial” Journal of agriculture and food chemistry. 2019 Jan9;67(1):184-192.


(16). Samarakoon K.W., Kwon O.N., Ko J.Y., Lee J.H., KangM.C., Kim D., Lee J.B., Lee J.S., Jeon Y.J. Purification and identification of novel angiotensin-I converting enzyme (ACE) inhibitory peptides from cultured marine microalgae (Nannochloropsis oculata) protein hydrolysate. J. Appl. Phycol. 2013;25:1595–1606. doi: 10.1007/s10811-013-9994-6.  


(17). Mori T. “Omega-3 fatty acidsand cardiovascular disease: epidemiology and effects on cardiometabolic riskfactors” Food & Function 2014 Sep;5(9):2004-19.


(18). Majumder K, Chakrabarti S, Morton JS, Panahi S, Kaufman S, Davidge ST, WuJ. Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats. PLoS One. 2013 Nov 29;8(11):e82829. doi:10.1371/journal.pone.0082829. PMID: 24312436; PMCID: PMC3843735.

(19). Fernández-Musoles R., Manzanares P.,Burguete M.C., Alborch E., Salom J.B. In vivo angiotensin I-converting enzyme inhibition by long-term intake of antihypertensive lactoferrin hydrolysate in spontaneously hypertensive rats. Food Res. Int. 2013;54:627–632. doi:10.1016/j.foodres.2013.07.063.

(20). Ejike C.E., Collins S.A.,Balasuriya N., Swanson A.K., Mason B., Udenigwe C.C. Prospects of microalgae proteins in producing peptide-based functional foods for promoting cardiovascular health. Trends Food Sci. Technol. 2017;59:30–36. doi: 10.1016/j.tifs.2016.10.026.


(21). Zhang Y, Bauersachs J, Langer HF. Immune mechanisms in heart failure. Eur JHeart Fail. 2017 Nov;19(11):1379-1389. doi: 10.1002/ejhf.942. Epub 2017 Sep 11.PMID: 28891154.


(22). Van Linthout S, Tschöpe C. Inflammation - Cause or Consequence of HeartFailure or Both? Curr Heart Fail Rep. 2017 Aug;14(4):251-265. doi:10.1007/s11897-017-0337-9. PMID: 28667492; PMCID: PMC5527060.


(23). Duda MK, O'Shea KM, Tintinu A, Xu W, Khairallah RJ, Barrows BR, Chess DJ,Azimzadeh AM, Harris WS, Sharov VG, Sabbah HN, Stanley WC. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res. 2009 Feb 1;81(2):319-27. doi:10.1093/cvr/cvn310. Epub 2008 Nov 17. PMID: 19015135; PMCID: PMC2721645.

(24). Higashikuni Y, Tanaka K, Kato M, Nureki O, Hirata Y, Nagai R, Komuro I,Sata M. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in responseto pressure overload through interleukin-1β upregulationvia nuclear factor κB activation.J Am Heart Assoc. 2013 Nov 18;2(6):e000267. doi: 10.1161/JAHA.113.000267. PMID:24249711; PMCID: PMC3886766.


(25). Serhan CN, Chiang N, Van Dyke TE. Resolvinginflammation: dual anti-inflammatory and pro-resolution lipid mediators. NatRev Immunol. 2008 May;8(5):349-61. doi: 10.1038/nri2294. PMID: 18437155; PMCID:PMC2744593.


(26). Serhan CN, Levy BD. Resolvins in inflammation: emergence of thepro-resolving superfamily of mediators. J Clin Invest. 2018 Jul2;128(7):2657-2669. doi: 10.1172/JCI97943. Epub 2018 May 14. PMID: 29757195;PMCID: PMC6025982.


(27). Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014 Jun 5;510(7503):92-101. doi: 10.1038/nature13479.PMID: 24899309; PMCID: PMC4263681.


(28). Watson JE, Kim JS, Das A. Emerging class of omega-3 fatty acid endocannabinoids& their derivatives. Prostaglandins Other Lipid Mediat. 2019Aug;143:106337. doi: 10.1016/j.prostaglandins.2019.106337. Epub 2019 May 11. PMID: 31085370; PMCID: PMC6685292.


(29). Toko H, Morita H, Katakura M, et al. Omega-3 fatty acid prevents the development of heart failure by changing fatty acid composition in the heart. Sci Rep. 2020;10(1):15553. Published 2020 Sep23. doi:10.1038/s41598-020-72686-0.


(30). Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R,Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM,Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L,Tognoni G, Tucci C, Valagussa F; GISSI-Prevenzione Investigators. Earlyprotection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GruppoItaliano per lo Studio della Sopravvivenza nell'Infarto Miocardico(GISSI)-Prevenzione. Circulation.2002 Apr 23;105(16):1897-903. doi: 10.1161/01.cir.0000014682.14181.f2. PMID:11997274.


(31). Singh RB, Dubnov G, Niaz MA, Ghosh S, Singh R, Rastogi SS, Manor O, PellaD, Berry EM. Effect of an Indo-Mediterranean diet on progression of coronaryartery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet. 2002 Nov 9;360(9344):1455-61. doi:10.1016/S0140-6736(02)11472-3. PMID: 12433513.


(32). Holy EW, Forestier M, Richter EK, Akhmedov A, Leiber F, Camici GG, MocharlaP, Lüscher TF, Beer JH, Tanner FC. Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation. Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1772-80.doi: 10.1161/ATVBAHA.111.226118. Epub 2011 May 12. PMID: 21571683.

(33). Winnik S, Lohmann C, Richter EK, SchäferN, Song WL, Leiber F, Mocharla P, Hofmann J, Klingenberg R, Borén J, Becher B,Fitzgerald GA, Lüscher TF, Matter CM, Beer JH. Dietary α-linolenic acid diminishes experimental atherogenesisand restricts T cell-driven inflammation. Eur Heart J. 2011 Oct;32(20):2573-84.doi: 10.1093/eurheartj/ehq501. Epub 2011 Jan 31. PMID: 21285075; PMCID:PMC3195262.

(34). SCAI “What is arterial plaque?” 2017.


(35). Lozano-Muñoz I, Muñoz S, Díaz NF, Medina A, Bazaes J, Riquelme C.Nutritional Enhancement of Farmed Salmon Meat via Non-GMO NannochloropsisGaditana: Eicosapentaenoic Acid (EPA, 20:5 n-3), Docosapentaenoic Acid (DPA,22:5 n-3) and Vitamin D3 for Human Health. Molecules. 2020;25(20):4615.Published 2020 Oct 10. doi:10.3390/molecules25204615.


(36). Hosseinzadeh Atar MJ, Hajianfar H, Bahonar A. The effects of omega-3 onblood pressure and the relationship between serum visfatin level and bloodpressure in patients with type II diabetes. ARYA Atheroscler.2012;8(1):27-31.

(37). Mayo Clinic. “Triglycerides:Why do they matter”. 2020.

(38). Zehr K, Walker M. “Omega-3 polyunsaturatedfatty acids improve endothelial function in humans at risk for atherosclerosis:A review”. January 2018, Pages 131-140.


(39). Colussi G, Catena C, Novello M, Bertin N, Sechi LA.Impact of omega-3 polyunsaturated fatty acids on vascular function and bloodpressure: Relevance for cardiovascular outcomes. Nutr Metab Cardiovasc Dis.2017 Mar;27(3):191-200. doi: 10.1016/j.numecd.2016.07.011. Epub 2016 Jul 26.PMID: 27692558.


(40). Filipovic MG, Aeschbacher S, Reiner MF, et al. Wholeblood omega-3 fatty acid concentrations are inversely associated with bloodpressure in young, healthy adults. JHypertens. 2018;36(7):1548-1554. doi:10.1097/HJH.0000000000001728.


(41). Hixson SM, Arts MT. Climate warming is predicted toreduce omega-3, long-chain, polyunsaturated fatty acid production inphytoplankton. Glob Chang Biol. 2016 Aug;22(8):2744-55. doi: 10.1111/gcb.13295.Epub 2016 Jun 6. PMID: 27070119.


(42). Gammone MA, Riccioni G, D'Orazio N. Carotenoids:potential allies of cardiovascular health?. Food Nutr Res. 2015;59:26762.Published 2015 Feb 6. doi:10.3402/fnr.v59.26762.


(43). Robbins M, Topol EJ. Inflammation in acute coronary syndromes. Cleve Clin JMed. 2002;69 Suppl 2:SII130-42. doi: 10.3949/ccjm.69.suppl_2.sii130. PMID:12086253.


(44). Di Tomo P, Canali R, Ciavardelli D, Di Silvestre S, De Marco A, GiardinelliA, Pipino C, Di Pietro N, Virgili F, Pandolfi A. β-Carotene andlycopene affect endothelial response to TNF-α reducingnitro-oxidative stress and interaction with monocytes. Mol Nutr Food Res. 2012Feb;56(2):217-27. doi: 10.1002/mnfr.201100500. Epub 2011 Dec 9. PMID: 22162208.


(45). Monroy-Ruiz J, Sevilla MÁ, Carrón R, Montero MJ. Astaxanthin-enriched-dietreduces blood pressure and improves cardiovascular parameters in spontaneouslyhypertensive rats. Pharmacol Res. 2011 Jan;63(1):44-50. doi:10.1016/j.phrs.2010.09.003. Epub 2010 Sep 22. PMID: 20868751.


(46). Preuss HG, Echard B, Yamashita E, Perricone NV. High dose astaxanthinlowers blood pressure and increases sensitivity in rats: are these effects interdependent? Int J Med Sci. 2011 Feb 9;8(2):126-38. doi:10.7150/ijms.8.126. PMID: 21326955; PMCID: PMC3039228.


(47). Ou HC, Chou WC, Chu PM, Hsieh PL, Hung CH, Tsai KL. Fucoxanthin Protectsagainst oxLDL-Induced Endothelial Damage via Activating the AMPK-Akt-CREB-PGC1α Pathway. Mol Nutr Food Res. 2019 May;63(10):e1801353.doi: 10.1002/mnfr.201801353. Epub 2019 Apr 10. PMID:30892786.


(48). Gammone MA, Gemello E, Riccioni G, D'Orazio N. Marine bioactives and potential application in sports. Mar Drugs. 2014 Apr 30;12(5):2357-82. doi:10.3390/md12052357. PMID: 24796298; PMCID: PMC4052294.


(49). D'Orazio N, Gemello E, Gammone MA, de Girolamo M, Ficoneri C, Riccioni G.Fucoxantin: a treasure from the sea. Mar Drugs. 2012 Mar;10(3):604-16. doi:10.3390/md10030604. Epub 2012 Mar 7. PMID: 22611357; PMCID: PMC3347018.

(50). D'Orazio N, Gammone MA, Gemello E, De Girolamo M, Cusenza S, Riccioni G.Marine bioactives: pharmacological properties and potential applicationsagainst inflammatory diseases. Mar Drugs. 2012 Apr;10(4):812-33. doi:10.3390/md10040812. Epub 2012 Apr 5. PMID: 22690145; PMCID: PMC3366677.


(51). Riccioni G, D'Orazio N, Franceschelli S, Speranza L. Marine carotenoids andcardiovascular risk markers. Mar Drugs.2011;9(7):1166-75. doi: 10.3390/md9071166. Epub 2011 Jun 27. PMID: 21822408;PMCID: PMC3148495.


(52). Klipstein-Grobusch K, Launer LJ, Geleijnse JM,Boeing H, Hofman A, Witteman JC. Serum carotenoids and atherosclerosis. The RotterdamStudy. Atherosclerosis. 2000 Jan;148(1):49-56. doi:10.1016/s0021-9150(99)00221-x. PMID:10580170.


(53). Rissanen T, Voutilainen S, Nyyssönen K, SalonenJT. Lycopene, atherosclerosis, and coronary heart disease. Exp Biol Med(Maywood). 2002 Nov;227(10):900-7. doi: 10.1177/153537020222701010. PMID:12424332.


(54). Rissanen TH, Voutilainen S, Nyyssönen K, Lakka TA, Sivenius J, Salonen R,Kaplan GA, Salonen JT. Low serum lycopene concentration is associated with anexcess incidence of acute coronary events and stroke: the Kuopio IschaemicHeart Disease Risk Factor Study. Br JNutr. 2001 Jun;85(6):749-54. doi: 10.1079/bjn2001357. PMID: 11430780.


(55). Agarwal S, Rao AV. Tomato lycopene and low density lipoprotein oxidation: ahuman dietary intervention study. Lipids. 1998 Oct;33(10):981-4. doi:10.1007/s11745-998-0295-6. PMID: 9832077.


(56). Hu MY, Li YL, Jiang CH, Liu ZQ, Qu SL, Huang YM. Comparison of lycopene andfluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.Nutrition. 2008 Oct;24(10):1030-8. doi: 10.1016/j.nut.2008.05.006. Epub 2008Jun 30. PMID: 18585898.


(57). McNulty H, Jacob RF, Mason RP. Biologic activity of carotenoids related todistinct membrane physicochemical interactions. Am J Cardiol. 2008 May22;101(10A):20D-29D. doi: 10.1016/j.amjcard.2008.02.004. PMID: 18474269.


(58). Jackson H, Braun CL, Ernst H. The chemistry of novel xanthophyllcarotenoids. Am J Cardiol. 2008 May 22;101(10A):50D-57D. doi:10.1016/j.amjcard.2008.02.008. PMID: 18474275.

(59). Seifried HE, Anderson DE, Fisher EI, Milner JA. A review of the interactionamong dietary antioxidants and reactive oxygen species. J Nutr Biochem. 2007 Sep;18(9):567-79. doi:10.1016/j.jnutbio.2006.10.007. Epub 2007 Mar 23. PMID: 17360173.


(60). Waller L, Krüger K, Conrad K, Weiss A, Alack K. Effects of Different Typesof Exercise Training on Pulmonary Arterial Hypertension: A SystematicReview. J Clin Med. 2020;9(6):1689. Published 2020 Jun 2.doi:10.3390/jcm9061689.


(61). Huang L, Trieu K, Yoshimura S, et al. Effect ofdose and duration of reduction in dietary sodium on blood pressure levels:systematic review and meta-analysis of randomised trials. BMJ.2020;368:m315. Published 2020 Feb 24. doi:10.1136/bmj.m315.


(62). Linneberg A, Jacobsen RK, Skaaby T, et al. Effect of Smoking on BloodPressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in theCARTA Consortium. Circ Cardiovasc Genet. 2015;8(6):832-841.doi:10.1161/CIRCGENETICS.115.001225.


(63). Bussotti M, Sommaruga M. Anxiety and depression in patients with pulmonaryhypertension: impact and management challenges. Vasc Health Risk Manag.2018;14:349-360. Published 2018 Nov 8. doi:10.2147/VHRM.S147173.


(64). Casas R, Castro-Barquero S, Estruch R, Sacanella E. Nutrition andCardiovascular Health. Int J Mol Sci. 2018;19(12):3988. Published 2018 Dec11. doi:10.3390/ijms19123988.